More

    Regeneron: What is Known about this Experimental Treatment Against the Coronavirus

    Must Read

    Costa Rica Will Host an Event Aimed at Strengthening Entrepreneurship Ecosystems

    Organizations and professionals dedicated to the development and accompaniment of ventures in Latin America have a virtual appointment on...

    China is the first major economy to launch its own official digital currency

    China already has its own digital currency: the Virtual Yuan, controlled by its Central Bank, according to a Wall...

    Changing the Way You Do Remote Work Will Prevent Virtual Meeting Fatigue

    The Pandemic is having a profound impact on the way we work; the disruption that we are going through...
    TCRN STAFFhttps://www.TheCostaRicaNews.com
    Creating a Conscious alternative news network that we feel the world needs. Pura Vida!

    The use of monoclonal antibodies is considered one of the most promising treatments for fighting COVID-19, and Regeneron is one of the pioneering companies to test them.

    According to specialists, they have the ability to be used as a fast-acting prophylactic drug in people exposed to the virus. Previously, Anthony Fauci, the US’s most recognized expert on viral diseases and leader of the White House team to fight the pandemic, had referred to this treatment as a possible “bridge to a vaccine.”

    While there are no treatments approved by the World Health Organization for COVID-19, the health protocol of this drug is one of the most promising candidates, according to US doctors.

    Regeneron notes that initial results suggest that the level of effects of the virus in the body can be reduced and possibly hospital stays shortened when administered early in the infection. Its use was authorized by the Food and Drug Administration (FDA).

    COVID

    What are monoclonal antibodies and why could they be an alternative to prevent COVID-19 while a vaccine is approved

    The protocol explains that REGN-COV2 is an experimental therapy for COVID-19 whose initial results show that it can produce an improvement in the symptoms of an infected person. Regeneron notes that its treatment was designed “specifically” to slow the effects of the Coronavirus.

    What are monoclonal antibodies?

    A monoclonal antibody, also known as mAB, is a type of drug that can be used both to prevent infection and to treat it after the disease has developed. When the body detects the presence of an antigen such as the Coronavirus, the immune system produces proteins designed to neutralize the virus in order to prevent it from entering our cells and reproducing. Monoclonal antibodies are synthetic copies made in the laboratory from a clone of a specific antibody found in the blood of a recovered person.

    Banner nuevo

    - Advertisement -
    - Advertisement -

    Latest News

    Costa Rica Will Host an Event Aimed at Strengthening Entrepreneurship Ecosystems

    Organizations and professionals dedicated to the development and accompaniment of ventures in Latin America have a virtual appointment on...
    - Advertisement -

    More Articles Like This

    - Advertisement -
    Language »